Clinical Trial Update: Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating long-term efficacy and tolerability of AP707 in chronic pain due to traumatic or post-operative peripheral neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Peripheral Neuralgia
• Peripheral Neuropathy
• Post-operative Pain
• Post-traumatic Neuralgia

Drugs mentioned

• AP707

Snippet

Sponsor: Apurano Pharmaceuticals GmbH | Conditions: Pain, Pain Syndrome | Phase 3 | Status: UNKNOWN